Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 20 de 389
Filter
1.
Epidemiology of mucormycosis in post-COVID-19 patients treated in a tertiary care hospital, Visakhapatnam, Andhra Pradesh
Journal of Family Medicine and Primary Care ; 11(11):6995-7000, 2022.
Article in English | CAB Abstracts | ID: covidwho-2225985
2.
Application of 4-aminoquinoline antimalarial drugs in virus infection
Journal of Tropical Medicine ; 22(4):593-597, 2022.
Article in Chinese | CAB Abstracts | ID: covidwho-2225880
3.
Artemisinins in combating viral infections like SARS-CoV-2, inflammation and cancers and options to meet increased global demand
Frontiers in Plant Science ; 13(February), 2022.
Article in English | CAB Abstracts | ID: covidwho-2224866
4.
Atovaquone for treatment of COVID-19: a prospective randomized, double-blind, placebo-controlled clinical trial
Frontiers in Pharmacology ; 13(September), 2022.
Article in English | CAB Abstracts | ID: covidwho-2224861
5.
Emergence of high colistin resistance in carbapenem resistant Acinetobacter baumannii in Pakistan and its potential management through immunomodulatory effect of an extract from Saussurea lappa
Frontiers in Pharmacology ; 13(September), 2022.
Article in English | CAB Abstracts | ID: covidwho-2224855
6.
Randomized, placebo-controlled, single-blind phase 1 studies of the safety, tolerability, and pharmacokinetics of BRII-196 and BRII-198, SARS-CoV-2 spike-targeting monoclonal antibodies with an extended half-life in healthy adults
Frontiers in Pharmacology ; 13(September), 2022.
Article in English | CAB Abstracts | ID: covidwho-2224854
7.
Hydroxychloroquine, azithromycin and methylprednisolone and in hospital survival in severe COVID-19 pneumonia
Frontiers in Pharmacology ; 13(September), 2022.
Article in English | CAB Abstracts | ID: covidwho-2224849
8.
Evaluation of the active constituents of Nilavembu Kudineer for viral replication inhibition against SARS-CoV-2: an approach to targeting RNA-dependent RNA polymerase (RdRp). (Special Issue: Pharma foods 3.0.)
Journal of Food Biochemistry ; 46(11), 2022.
Article in English | CAB Abstracts | ID: covidwho-2223404
9.
Phytochemical analysis of ethanolic extract of fruits of Terminalia chebula and its medicinal use in human
Pharmacology Online ; 2:43-54, 2021.
Article in English | CAB Abstracts | ID: covidwho-2218557
10.
Real-world effectiveness of molnupiravir and nirmatrelvir plus ritonavir against mortality, hospitalisation, and in-hospital outcomes among community-dwelling, ambulatory patients with confirmed SARS-CoV-2 infection during the omicron wave in Hong Kong: an observational study
Lancet ; 400(10359):1213-1222, 2022.
Article in English | CAB Abstracts | ID: covidwho-2184592
11.
Purulent lymphadenitis due to coronavirus disease 2019: a case report
International Journal of Infectious Diseases ; 125:145-148, 2022.
Article in English | CAB Abstracts | ID: covidwho-2179525
12.
Effect of corticosteroids in patients with COVID-19: a Bayesian network meta-analysis. (Special Issue: Coronavirus (COVID-19) collection.)
International Journal of Infectious Diseases ; 125:84-92, 2022.
Article in English | CAB Abstracts | ID: covidwho-2179524
13.
Model exploration for discovering COVID-19 targeted traditional Chinese medicine. (Special Issue: Pharmaceutical science, pharmacology, toxicology.)
Heliyon ; 8(12), 2022.
Article in English | CAB Abstracts | ID: covidwho-2179026
14.
The comparison of the mortality rates of plasmapheresis/hemoperfusion therapy with current treatment among COVID-19 patients. (Special Issue: Clinical research.)
Heliyon ; 8(11), 2022.
Article in English | CAB Abstracts | ID: covidwho-2179008
15.
Clinical safety and pharmacokinetic evaluation of aqueous extract of Cocculus hirsutus, an anti-viral phytopharmacetical drug as a potential for the treatment of Dengue and COVID-19. (Special Issue: Pharmaceutical science, pharmacology, toxicology.)
Heliyon ; 8(5), 2022.
Article in English | CAB Abstracts | ID: covidwho-2178990
16.
A network-biology led computational drug repurposing strategy to prioritize therapeutic options for COVID-19. (Special Issue: Biology.)
Heliyon ; 8(5), 2022.
Article in English | CAB Abstracts | ID: covidwho-2178987
17.
Effect of liushen capsules (pill) on antiviral activity of COVID-19 in vitro and in patients with positive nucleic acid for more than 14 days
Chinese Journal of Integrated Traditional and Western Medicine ; 42(9):1080-1086, 2022.
Article in English, Chinese | CAB Abstracts | ID: covidwho-2169892
18.
Effect of Mycobacterium w on IL-6 and oxygen requirement in COVID-19
Journal of the Association of Physicians of India ; 70(June):56-58, 2022.
Article in English | CAB Abstracts | ID: covidwho-2169723
19.
Clinical profile and outcome of post COVID mucormycosis patients in a tertiary care centre in Kumaon Region, India
Jundishapur Journal of Microbiology ; 15(1):6642-6653, 2022.
Article in English | CAB Abstracts | ID: covidwho-2169498
20.
Refractory chest pain in mild to moderate Coronavirus disease 2019 successfully treated with saikanto, a Japanese traditional medicine
Tohoku Journal of Experimental Medicine ; 257(3):241-249, 2022.
Article in English | CAB Abstracts | ID: covidwho-2167596
SEND TO:
Email
Export
Print
RSS
XML
SELECTION OF CITATIONS
SEARCH DETAIL